Rice University lab employs clotting powers of viper-derived drug, even in presence of anti-coagulants
A nanofiber hydrogel infused with snake venom may be the best material to stop bleeding quickly, according to Rice University scientists.
The hydrogel called SB50 incorporates batroxobin, a venom produced by two species of South American pit viper. It can be injected as a liquid and quickly turns into a gel that conforms to the site of a wound, keeping it closed, and promotes clotting within seconds.
Rice chemist Jeffrey Hartgerink, lead author Vivek Kumar and their colleagues reported their discovery in the American Chemical Society journal ACS Biomaterials Science and Engineering. The hydrogel may be most useful for surgeries, particularly for patients who take anti-coagulant drugs to thin their blood.
“It’s interesting that you can take something so deadly and turn it into something that has the potential to save lives,” Hartgerink said.
Batroxobin was recognized for its properties as a coagulant – a substance that encourages blood to clot – in 1936. It has been used in various therapies as a way to remove excess fibrin proteins from the blood to treat thrombosis and as a topical hemostat. It has also been used as a diagnostic tool to determine blood-clotting time in the presence of heparin, an anti-coagulant drug.
“From a clinical perspective, that’s far and away the most important issue here,” Hartgerink said. “There’s a lot of different things that can trigger blood coagulation, but when you’re on heparin, most of them don’t work, or they work slowly or poorly. That obviously causes problems if you’re bleeding.
“Heparin blocks the function of thrombin, an enzyme that begins a cascade of reactions that lead to the clotting of blood,” he said. “Batroxobin is also an enzyme with similar function to thrombin, but its function is not blocked by heparin. This is important because surgical bleeding in patients taking heparin can be a serious problem. The use of batroxobin allows us to get around this problem because it can immediately start the clotting process, regardless of whether heparin is there or not.”
The batroxobin combined with the Rice lab’s hydrogels isn’t taken directly from snakes, Hartgerink said. The substance used for medicine is produced by genetically modified bacteria and then purified, avoiding the risk of other contaminant toxins.
The Rice researchers combined batroxobin with their synthetic, self-assembling nanofibers, which can be loaded into a syringe and injected at the site of a wound, where they reassemble themselves into a gel.
Tests showed the new material stopped a wound from bleeding in as little as six seconds, and further prodding of the wound minutes later did not reopen it. The researchers also tested several other options: the hydrogel without batroxobin, the batroxobin without the hydrogel, a current clinical hemostat known as GelFoam and an alternative self-assembling hemostat known as Puramatrix and found that none were as effective, especially in the presence of anti-coagulants.
The new work builds upon the Rice lab’s extensive development of injectable hydrogel scaffolds that help wounds heal and grow natural tissue. The synthetic scaffolds are built from the peptide sequences to mimic natural processes.
“To be clear, we did not discover nor do any of the initial investigations of batroxobin,” Hartgerink said. “Its properties have been well-known for many decades. What we did was combine it with the hydrogel we’ve been working on for a long time.
The Latest on: Nanofiber hydrogel
via Google News
The Latest on: Nanofiber hydrogel
- Yokogawa Bio Frontier commences production of sulfated cellulose nanofiberson June 17, 2021 at 8:08 am
Yokogawa Bio Frontier, Inc., a subsidiary of Yokogawa Electric Corp. (Tokyo), announced that it has commenced sales of 100% plant-derived sulfated ...
- Yokogawa Bio Frontier Commences Sales of S-CNF - A High-Performance Nanocellulose Materialon June 15, 2021 at 11:47 am
In addition to having the same characteristics as standard cellulose nanofiber, S-CNF in a gel form can be dried to produce a powdered substance that has approximately 1/100th the volume and weight of ...
- Global Scaffold Technology Market to Reach $1.7 Billion by 2027on June 11, 2021 at 6:45 am
utm_source=GNW 7 Billion by 2027, growing at a CAGR of 7.7% over the analysis period 2020-2027. Hydrogels, one of the segments analyzed in the report, is projected to record a 8% CAGR and reach US$772 ...
- Scaffold Technology Market Size Worth $2.1 Billion By 2028 | CAGR: 8.4%: Grand View Research, Inc.on May 26, 2021 at 1:43 am
Key suggestions from the report: The hydrogels segment dominated the market ... contributing to its increasing adoption rate The nanofiber-based scaffolds segment is expected to witness lucrative ...
- Probiotic Hydrogels Designed as Spray-On Bandage for Intestineson May 20, 2021 at 5:00 pm
One latest use for this type of materials comes from Harvard University, where researchers have developed probiotic hydrogels that can be used to help intestinal wounds heal and promote intestinal ...
via Bing News